Hyderabad-based drugmaker Aurobindo Pharma's US arm is recalling nearly 5 lakh bottles of blood pressure lowering drugs from the US market. This comes after certain deviations from Current Good Manufacturing Practice (CGMP) regulations were found in them. Notably, other pharmaceutical companies like Lupin and Sun Pharma recently recalled some drugs in the US due to presence of particulate matter.